(VIANEWS) – BOLLORE (BOL.PA), UCB (UCB.BR), BUREAU VERITAS (BVI.PA) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio so far. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. BOLLORE (BOL.PA)
100% Payout Ratio
Bolloré SE engages in the transportation and logistics, communications, and industry businesses in France, rest of Europe, the Americas, Asia, Oceania, and Africa. It operates through Bolloré Logistics, Bolloré Energy, Communications, and Industry segments. The company offers freight forwarding, railroad, and port services; and distributes oil products. It also provides advertising, and communication consulting services; owns and publishes Cnews, a French daily newspaper; provides ticketing and venue services; acts as a pay-TV operator; and operates Mac-Mahon cinema theaters. In addition, it develops batteries based on lithium metal polymer technology for use in electric buses and energy storage solutions, as well as in stationary applications; and polypropylene films for capacitors and electrical components. Further, the company integrates identification, tracking, and mobility solutions for retail, transport, and logistics; provides equipment for pedestrian and vehicle access control; and electric shuttles solutions. The company was founded in 1822 and is based in Puteaux, France. Bolloré SE is a subsidiary of Financière de l'Odet SE.
Earnings Per Share
As for profitability, BOLLORE has a trailing twelve months EPS of €0.06.
PE Ratio
BOLLORE has a trailing twelve months price to earnings ratio of 100.58. Meaning, the purchaser of the share is investing €100.58 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.04%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 20, 2023, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 0.99%.
Yearly Top and Bottom Value
BOLLORE’s stock is valued at €6.03 at 02:10 EST, below its 52-week high of €6.37 and way above its 52-week low of €4.31.
More news about BOLLORE.
2. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €2.19.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 39.57. Meaning, the purchaser of the share is investing €39.57 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 1.53%.
Yearly Top and Bottom Value
UCB’s stock is valued at €86.66 at 02:10 EST, under its 52-week high of €88.80 and way higher than its 52-week low of €66.62.
Volume
Today’s last reported volume for UCB is 44269 which is 83.18% below its average volume of 263282.
Sales Growth
UCB’s sales growth for the current quarter is negative 5.3%.
More news about UCB.
3. BUREAU VERITAS (BVI.PA)
54.08% Payout Ratio
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products. The company engages in inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its customers in relation to regulatory or self-imposed standards, as well as issues compliance reports. It also provides laboratory and on-site testing services for manufacturing and process industries; inspection services for products, services, assets, and installations, as well as various services designed to control quality, verify quantity, and meet regulatory requirements; and certification services for management systems, products, and people. The company serves automotive and transportation, building and infrastructure, chemicals, commodities and agriculture, consumer products and retail, food, marine and offshore, oil and gas, and power and utilities industries, as well as financial services and public sectors. It operates in approximately 140 countries through a network of 1,600 offices and laboratories. Bureau Veritas SA was founded in 1828 and is headquartered in Neuilly-sur-Seine, France.
Earnings Per Share
As for profitability, BUREAU VERITAS has a trailing twelve months EPS of €0.96.
PE Ratio
BUREAU VERITAS has a trailing twelve months price to earnings ratio of 25.57. Meaning, the purchaser of the share is investing €25.57 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.66%.
Yearly Top and Bottom Value
BUREAU VERITAS’s stock is valued at €24.55 at 02:10 EST, way under its 52-week high of €27.32 and way higher than its 52-week low of €22.29.
Volume
Today’s last reported volume for BUREAU VERITAS is 171681 which is 75.84% below its average volume of 710723.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 0.77 and the estimated forward annual dividend yield is 3.16%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 5.65B for the twelve trailing months.
More news about BUREAU VERITAS.
4. OENEO (SBT.PA)
47.62% Payout Ratio
Oeneo SA operates in the wine industry worldwide. The company manufactures and sale of cork closures. It also provides solutions in wine making and spirits. Oeneo SA is headquartered in Bordeaux, France. Oeneo SA is a subsidiary of Caspar SAS.
Earnings Per Share
As for profitability, OENEO has a trailing twelve months EPS of €0.64.
PE Ratio
OENEO has a trailing twelve months price to earnings ratio of 21.41. Meaning, the purchaser of the share is investing €21.41 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.71%.
Yearly Top and Bottom Value
OENEO’s stock is valued at €13.70 at 02:10 EST, way under its 52-week high of €16.80 and higher than its 52-week low of €12.85.
Volume
Today’s last reported volume for OENEO is 252 which is 95.28% below its average volume of 5348.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 340.62M for the twelve trailing months.
Sales Growth
OENEO’s sales growth is 6.7% for the ongoing quarter and 6.7% for the next.
More news about OENEO.
5. SMURFIT KAPPA GP (SK3.IR)
35.3% Payout Ratio
Smurfit Kappa Group plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in the Americas and Europe. The company offers e-commerce, retail, consumer, industrial, bottle, protective, heavy-duty, hexacomb, and various punnet packaging products; composite cardboard tubes, bags, and sacks; and bag-in-box, a packaging system that comprises films, accessories, bags, taps, and boxes. It also provides point of sale displays; cardboards of social distancing; corrugated sheet boards, solid board sheets, folding carton sheet boards, sack Kraft papers, MG brown Kraft papers, preprint products, agro-papers, technical papers, BanaBag, and Catcher Board MB12; various types of containerboards, such as Kraftliners, testliners, and containerboard flutings; and solid board sheets. In addition, the company offers recycling solutions to cardboard and paper products; and supplies packaging machinery. It primarily serves consumer goods, industrial goods, and food and drink sectors. Smurfit Kappa Group plc was founded in 1934 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, SMURFIT KAPPA GP has a trailing twelve months EPS of €3.59.
PE Ratio
SMURFIT KAPPA GP has a trailing twelve months price to earnings ratio of 9.58. Meaning, the purchaser of the share is investing €9.58 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.04%.
More news about SMURFIT KAPPA GP.
